Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

‘No shortcuts’ on H1N1 vaccine safety says GlaxoSmithKline

August 20, 2009 Research and Development, Sales and Marketing GSK, h1n1, vaccines

GlaxoSmithKline says the public need not doubt the safety of its vaccine against the H1N1 swine flu, which it is …
News

Avastin shows promise in advanced breast cancer

August 20, 2009 Research and Development, Sales and Marketing Roche, avastin, breast cancer

Avastin's rise continues as new data suggests it improves progression-free survival as a second line treatment for advanced breast cancer.The …
News

Obstacles remain for patients with blood cancers

August 20, 2009 Research and Development, Sales and Marketing NICE, blood cancer

News

Manchester research hub appoints industry liaison

August 19, 2009 Research and Development Academic, NHS

The Manchester Biomedical Research Centre (BRC) has appointed a new industry-facing executive to forge new research links with the industry.Dr …
News

Novartis’ Extavia approved in US

August 19, 2009 Research and Development, Sales and Marketing Extavia, MS, Novartis

 Novartis has received US approval for its betaferon product for multiple sclerosis.Extavia’s active ingredient is interferon beta-1b, putting it into …
News

US pharma accused of selling out to Obama

August 19, 2009 Research and Development, Sales and Marketing US, US healthcare, healthcare, industry

The US industry is accused of selling out to President Obama’s healthcare take-over, with its leaders seeking favourable treatment from …
News

Off-label rules for cancer need to be clarified

August 18, 2009 Research and Development, Sales and Marketing Cancer, NHS, off label

A new report is pressing for the off label prescribing of drugs to be made clearer and more fair for …
News

ClinPhone accounts give Parexel a hangover

August 18, 2009 Research and Development Clinphone

Accounting errors at recently-acquired ClinPhone pegged back Parexel's operating profits in its latest quarterly reports, and it will be some …
News

GSK starts first trials for H1N1 vaccine in Germany

August 17, 2009 Research and Development, Sales and Marketing GSK, h1n1, vaccines

GSK is to embark on the clinical development for its pandemic swine flu vaccine, completing enrolment into its first study …
News

Genzyme says Cerezyme shortages could last longer than expected

August 17, 2009 Research and Development, Sales and Marketing Gaucher, Genzyme

The shortage of Genzyme's enzyme replacement therapy Cerezyme look set to last longer than expected, as the company has taken …
News

Vulnerable groups first in line for UK swine flu jabs

August 14, 2009 Research and Development, Sales and Marketing NHS, h1n1

The first 11 million people to receive jabs against the H1N1 virus have been announced by the government, ready for …
News

Animal rights attacks were terrorism not activism, says Vasella

August 13, 2009 Research and Development, Sales and Marketing Animal tests, Novartis, Vasella

Novartis chief executive Daniel Vasella has spoken for the first time of his shock at the arson attack on his …
News

AZ signs antibiotic deal with Forest Laboratories

August 13, 2009 Research and Development, Sales and Marketing Antibiotics, Forest

AstraZeneca has struck a deal with Forest Laboratories to co-develop and commercialise ceftaroline, an anti-infective drug in phase III. The …
News

Authorised generics deals likely here to stay, says analyst

August 12, 2009 Research and Development, Sales and Marketing generics

The practice of branded drugmakers paying rivals to keep generics off the market after product patent expiry – known as …
News

EMEA makes adverse drug reaction research a priority

August 12, 2009 Research and Development, Sales and Marketing Europe, drug safety

Adverse drug reaction in hyperactive children has been made a key research priority for next year by the European Medicines …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026